The discovery and early days of TGF-b: A historical perspective

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 7, 2016, Pages

  Moses, Harold L ^a   Roberts, Anita B ^b   Derynck, Rik ^c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY;

ANIMALS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84977475925     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a021865     Document Type: Article

References (219)

1. Akhurst RJ, Derynck R. 2001 TGF-b signaling in cancer—A double-edged sword. Trends Cell Biol 11: S44–S51
2. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. 2001 TGF-b-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20: 2254–2272
3. Anzano MA, Roberts AB, Smith JM, Lamb LC, Sporn MB. 1982 Purification by reverse-phase high-performance liquid chromatography of an epidermal growth factordependent transforming growth factor. Anal Biochem 125: 217–224
4. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. 1983 Transforming growth factor b in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258: 7155–7160
5. Attisano L, Wrana JL, Cheifetz S, Massagué J. 1992 Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68: 97–108
6. Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL. 1993 Identification of human activin and TGF-b type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671–80
7. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, deWinter JP, Uilenbroek JT, Karels B, Wilming LG, Meijers JH, et al. 1994 A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120: 189–197
8. Bai S, Cao X. 2002 A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor b signaling. J Biol Chem 277: 4176–4182
9. Baker JC, Harland RM. 1996 A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 10: 1880–1889
10. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF. 1994 A transforming growth factor b type I receptor that signals to activate gene expression. Science 263: 87–89
11. Bauer H, Lele Z, Rauch GJ, Geisler R, Hammerschmidt M. 2001 The type I serine/threonine kinase receptor Alk8/ Lost-a-fin is required for Bmp2b/7 signal transduction during dorsoventral patterning of the zebrafish embryo. Development 128: 849–858
12. Bernabeu C, Lopez-Novoa JM, Quintanilla M. 2009 The emerging role of TGF-b superfamily coreceptors in cancer. Biochim Biophys Acta 1792: 954–973
13. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. 1990 Suppression of experimental glomerulonephritis by antiserum against transforming growth factor b1 Nature 346: 371–374
14. Briones-Orta MA, Tecalco-Cruz AC, Sosa-Garrocho M, Caligaris C, Macías-Silva M. 2011 Inhibitory Smad7: Emerging roles in health and disease. Curr Mol Pharmacol 4: 141–153
15. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, et al. 1986 Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45: 685–698
16. Chapman HA. 2011 Epithelial–mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 73: 413–435
17. Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R, Massagué J. 1987 The transforming growth factor b system, a complex pattern of cross-reactive ligands and receptors. Cell 48: 409–415
18. Cheifetz S, Ling N, Guillemin R, Massagué J. 1988 A surface component on GH3 pituitary cells that recognizes transforming growth factor b, activin, and inhibin. J Biol Chem 263: 17225–17228
19. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M. 1992 Endoglin is a component of the transforming growth factor b receptor system in human endothelial cells. J Biol Chem 267: 19027–19030
20. Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R. 1995 AWD-domain protein that is associated with and phosphorylated by the type II TGF-b receptor. Nature 377: 548–552
21. Chen X, Rubock MJ, Whitman M. 1996 A transcriptional partner for MAD proteins in TGF-b signaling. Nature 383: 691–696 (Erratum in Nature 384: 648).
22. Chen YG, Liu F, Massagué J. 1997 Mechanism of TGF-b receptor inhibition by FKBP12 EMBO J 16: 3866–3876
23. Chen CR, Kang Y, Siegel PM, Massagué J. 2002 E2F4/5 and p107 as Smad cofactors linking the TGF-b receptor to c-myc repression. Cell 110: 19–32
24. Childs CB, Proper JA, Tucker RF, Moses HL. 1982 Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci 79: 5312–5316
25. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ. 1996 TGF-b1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531–542
26. Davoren PR. 1962 The isolation of insulin from a single cat pancreas. Biochim Biophys Acta 63: 150–153
27. De Larco JE, Todaro GJ. 1978 Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci 75: 4001–4005.
28. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlüsener H, Seifert JM, Bodmer S, Fontana A, Hofer E. 1987 Complementary DNA for human glioblastoma- derived T cell suppressor factor, a novel member of the transforming growth factor b gene family. EMBO J 6: 3673–3677
29. Derynck R, Rhee L. 1987 Sequence of the porcine transforming growth factor b precursor. Nucleic Acids Res 15: 3187
30. Derynck R, Zhang Y. 1996 Intracellular signalling: The Mad way to do it. Curr Biol 6: 1226–1229
31. Derynck R, Zhang YE. 2003 Smad-dependent and Smadindependent pathways in TGF-b family signalling. Nature 425: 577–584
32. Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV. 1984 Human transforming growth factor a: Precursor structure and expression in E. coli. Cell 38: 287–297
33. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR., Assoian RK, Roberts AB, Sporn MB, Goeddel DV. 1985 Human transforming growth factor b complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701–705
34. Derynck R, Jarrett JA, Chen EY, Goeddel DV. 1986 The murine transforming growth factor b precursor. J Biol Chem 261: 4377–4379
35. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. 1987 Synthesis of messenger RNAs for transforming growth factors a and b and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707–712
36. Derynck R, Lindquist PB, Lee A, Wen D, Tamm J, Graycar JL, Rhee L, Mason AJ, Miller DA, Coffey RJ, et al. 1988 A new type of transforming growth factor b, TGF-b3 EMBO J 7: 3737–3743
37. Derynck R, Gelbart WM, Harland RM, Heldin CH, Kern SE, Massagué J, Melton DA, Mlodzik M, Padgett RW, Roberts AB, et al. 1996 Nomenclature: Vertebrate mediators of TGF-b family signals. Cell 87: 173
38. Derynck R, Zhang Y, Feng XH. 1998 Smads: Transcriptional activators of TGF-b responses. Cell 95: 737–740
39. Derynck R, Akhurst RJ, Balmain A. 2001 TGF-b signaling in tumor suppression and cancer progression. Nat Genet 29: 117–129
40. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995 Defective haematopoiesis and vasculogenesis in transforming growth factor b1 knock out mice. Development 121: 1845–1854.
41. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R. 1994 Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 8: 1006–1020
42. Doyle JJ, Gerber EE, Dietz HC. 2012 Matrix-dependent perturbation of TGF-b signaling and disease. FEBS Lett 586: 2003–2015
43. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. 1995 Processing of transforming growth factor b1 precursor by human furin convertase. J Biol Chem 270: 10618–10624
44. Dvorak HF. 1986 Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650–1659
45. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R. 1993a. Cloning of a type I TGF-b receptor and its effect on TGF-b binding to the type II receptor. Science 260: 1344–1348
46. Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R. 1993b. Determination of type I receptor specificity by the type II receptors for TGF-b or activin. Science 262: 900–902
47. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK. 1987 Transforming growth factor b modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899–1904
48. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, et al. 1996 MADR2 maps to 18q21 and encodes a TGF-b-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543–552
49. Estevez M, Attisano L, Wrana JL, Albert PS, Massagué J, Riddle DL. 1993 The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature 365: 644–649
50. Feng XH, Derynck R. 2005 Specificity and versatility in TGF-b signaling through Smads. Annu Rev Cell Dev Biol 21: 659–693
51. Fowlis DJ, Cui W, Johnson SA, Balmain A, Akhurst RJ. 1996 Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor b1 in the skin of transgenic mice. Cell Growth Differ 7: 679–687
52. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K. 1993 Cloning of a TGF-b type I receptor that forms a heteromeric complex with the TGF-b type II receptor. Cell 75: 681–692
53. Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB. 1983 Purification and initial characterization of a type b transforming growth factor from human placenta. Proc Natl Acad Sci 80: 3676–3680
54. Frolik CA, Wakefield LM, Smith DM, Sporn MB. 1984 Characterization of a membrane receptor for transforming growth factor b in normal rat kidney fibroblasts. J Biol Chem 259: 10995–11000
55. Gentry LE, Webb NR, Lim GJ, Brunner AM, Ranchalis JE, Twardzik DR, Lioubin MN, Marquardt H, Purchio AF. 1987 Type 1 transforming growth factor b: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol Cell Biol 7: 3418–3427
56. Gentry LE, Lioubin MN, Purchio AF, Marquardt H. 1988 Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor b to the mature polypeptide. Mol Cell Biol 8: 4162–4168
57. Georgi LL, Albert PS, Riddle DL. 1990. daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 61: 635–645
58. Gougos A, Letarte M. 1990 Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265: 8361–8364
59. Graff JM, Bansal A, Melton DA. 1996 XenopusMad proteins transduce distinct subsets of signals for the TGF-b superfamily. Cell 85: 479–487
60. Gray AM, Mason AJ. 1990 Requirement for activin A and transforming growth factor b1 pro-regions in homodimer assembly. Science 247: 1328–1330
61. Griswold-Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R. 1998 Physical and functional interactions between type I transforming growth factor b receptors and Ba, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol 18: 6595–6604
62. Grönroos E, Hellman U, Heldin CH, Ericsson J. 2002 Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell 10: 483–493
63. Gruppuso PA, Mikumo R, Brautigan DL, Braun L. 1991 Growth arrest induced by transforming growth factor b1 is accompanied by protein phosphatase activation in human keratinocytes. J Biol Chem 266: 3444–3448
64. Haddow A. 1972 Molecular repair, wound healing, and carcinogenesis: Tumor production a possible overhealing? Adv Cancer Res 16: 181–234
65. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, et al. 1996 DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271: 350–353
66. Hanks SK, Armour R, Baldwin JH, Maldonado F, Spiess J, Holley RW. 1988 Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci 85: 79–82
67. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. 1998 Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186–197
68. Hay ED. 1995 An overviewof epithelio-mesenchymal transformation. Acta Anat (Basel) 154: 8–20
69. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr., Wrana JL, et al. 1997 The MAD-related protein Smad7 associates with the TGF-b receptor and functions as an antagonist of TGF-b signaling. Cell 89: 1165–1173
70. He WW, Gustafson ML, Hirobe S, Donahoe PK. 1993 Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor b type II receptor family. Dev Dyn 196: 133–142
71. Heine U, Munoz EF, Flanders KC, Ellingsworth LR, Lam HY, Thompson NL, Roberts AB, Sporn MB. 1987 Role of transforming growth factor b in the development of the mouse embryo. J Cell Biol 105: 2861–2876
72. Heino J, Ignotz RA, Hemler ME, Crouse C, Massagué J. 1989 Regulation of cell adhesion receptors by transforming growth factor b. Concomitant regulation of integrins that share a common b1 subunit. J Biol Chem 264: 380–388
73. Holley RW. 1972 A unifying hypothesis concerning the nature of malignant growth. Proc Natl Acad Sci 69: 2840–2841
74. Holley RW. 1975 Control of growth of mammalian cells in culture. Nature 258: 487–490
75. Holley RW, Armour R, Baldwin JH. 1978 Density-dependent regulation of growth of BSC-1 cells in cell culture: Growth inhibitors formed by the cells. Proc Natl Acad Sci 75: 1864–1866
76. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O’Connor MB, Attisano L, Wrana JL. 1996 MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489–500
77. Hua X, Liu X, Ansari DO, Lodish HF. 1998 Synergistic cooperation of TFE3 and smad proteins in TGF-b-induced transcription of the plasminogen activator inhibitor- 1 gene. Genes Dev 12: 3084–3095
78. Huang SS, Huang JS. 2005 TGF-b control of cell proliferation. J Cell Biochem 96: 447–462
79. Ignotz RA, Massagué J. 1987 Cell adhesion protein receptors as targets for transforming growth factor b action. Cell 51: 189–197
80. Ikushima H, Miyazono K. 2010 TGF-b signalling: A complex web in cancer progression. Nat Rev Cancer 10: 415– 424
81. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. 1997 Smad6 inhibits signalling by the TGF-b superfamily. Nature 389: 622–626
82. Jhappan C, Geiser AG, Kordon EC, Bagheri D, Hennighausen L, Roberts AB, Smith GH, Merlino G. 1993 Targeting expression of a transforming growth factor b1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12: 1835–1845
83. Kang JS, Alliston T, Delston R, Derynck R. 2005 Repression of Runx2 function by TGF-b through recruitment of class II histone deacetylases by Smad3 EMBO J 24: 2543–2555
84. Kanzaki T, Olofsson A, Morén A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin CH. 1990 TGFb1 binding protein: A component of the large latent complex of TGF-b1 with multiple repeat sequences. Cell 61: 1051–1061
85. Katsuno Y, Lamouille S, Derynck R. 2013 TGF-b signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25: 76–84
86. Kawabata M, Chytil A, Moses HL. 1995 Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor b receptor. J Biol Chem 270: 5625–5630
87. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. 1986a. Transforming growth factor b is an important immunomodulatory protein for human B lymphocytes. J Immunol 137: 3855–3860
88. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez- Mon M, Derynck R, Sporn MB, Fauci AS. 1986b. Production of transforming growth factor b by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 1037–1050
89. Kerr LD, Olashaw NE, Matrisian LM. 1988 Transforming growth factor b1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J Biol Chem 263: 16999–17005
90. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A. 1997 Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388: 304–308
91. Kramer IM, Koornneef I, de Laat SW, van den Eijnden-van Raaij AJ. 1991 TGF-b1 induces phosphorylation of the cyclic AMP responsive element binding protein in MLCCl64 cells. EMBO J 10: 1083–1089
92. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. 1993 Transforming growth factor b1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci 90: 770–774
93. Labbé E, Silvestri C, Hoodless PA, Wrana JL, Attisano L. 1998 Smad2 and Smad3 positively and negatively regulate TGF-b-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 2: 109–120
94. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. 1996 Partnership between DPC4 and SMAD proteins in TGFb signalling pathways. Nature 383: 832–836
95. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. 1986 Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor b. J Cell Biol 103: 2403–2410
96. Laiho M, Weis FMB, Boyd FT, Ignotz RA, Massagué J. 1991 Responsiveness to transforming growth factor b restored by complementation between cells defective in TGF-b receptors I and II. J Biol Chem 286: 9106–9112
97. Lamouille S, Xu J, Derynck R. 2014.Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 15: 178–196
98. Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P. 1984 Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 121: 184– 188
99. Lawrence DA, Pircher R, Jullien P. 1985 Conversion of a high molecular weight latent b-TGF from chicken embryo fibroblasts into a low molecular weight active b- TGF under acidic conditions. Biochem Biophys Res Commun 133: 1026–1034
100. Lehnert SA, Akhurst RJ. 1988 Embryonic expression pattern of TGF-b type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 104: 263–273
101. Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto PE, Moses HL. 1986 Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor b: A proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci 83: 2453–2457
102. Letterio JJ, Roberts AB. 1998 Regulation of immune responses by TGF-b. Annu Rev Immunol 16: 137–161
103. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. 1994 Maternal rescue of transforming growth factor b1 null mice. Science 264: 1936–1938
104. Levinson AD, Oppermann H, Levintow L, Varmus HE, Bishop JM. 1978 Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein. Cell 15: 561–572
105. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. 1992 Expression cloning of the TGF-b type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785
106. Liu F, Ventura F, Doody J, Massagué J. 1995 Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15: 3479–3486
107. Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, Massagué J. 1996 A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620–623
108. Liu D, Black BL, Derynck R. 2001 TGF-b inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3 Genes Dev 15: 2950–2966
109. Liu D, Kang JS, Derynck R. 2004 TGF-b-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J 23: 1557–1566
110. Lopez-Casillas F, Cheifetz S, Doody J, Andrés JL, Lane WS, Massagué J. 1991 Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-b receptor system. Cell 67: 785–795
111. Lopez-Casillas F, Wrana JL, Massagué J. 1993 Betaglycan presents ligand to the TGF-b signaling receptor. Cell 73: 1435–1444
112. Lyons RM, Keski-Oja J, Moses HL. 1988 Proteolytic activation of latent transforming growth factor b from fibroblast- conditioned medium. J Cell Biol 106: 1659–1665
113. Macías-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. 1996 MADR2 is a substrate of the TGF-b receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215–1224
114. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B. 1995 Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338
115. Marquardt H, Lioubin MN, Ikeda T. 1987 Complete amino acid sequence of human transforming growth factor type b2 J Biol Chem 262: 12127–12131
116. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H, Seeburg PH. 1985 Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor b. Nature 318: 659–663
117. Massagué J. 1990 The transforming growth factor b family. Annu Rev Cell Biol 6: 597–641
118. Massagué J. 2008 TGF-b in cancer. Cell 134: 215–230
119. Massagué J, Like B. 1985 Cellular receptors for type b transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem 260: 2636–2645
120. Massagué J, Czech MP, Iwata K, De Larco JE, Todaro GJ. 1982 Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. Proc Natl Acad Sci 79: 6822–6826
121. Massagué J, Seoane J, Wotton D. 2005 Smad transcription factors. Genes Dev 19: 2783–2810
122. Mathews LS, Vale WW. 1991 Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65: 973–982
123. Mathews LS, Vale WW, Kintner CR. 1992 Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 255: 1702–1705
124. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al. 1994 Endoglin, a TGF-b binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 8: 345– 351
125. McDonald NQ, Hendrickson WA. 1993 A structural superfamily of growth factors containing a cystine knot motif. Cell 73: 421–424
126. Miettinen PJ, Ebner R, Lopez AR, Derynck R. 1994 TGF-b induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J Cell Biol 127: 2021–2036
127. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. 1991 Embryonic gene expression patterns of TGF-b1, b2 and b3 suggest different developmental functions in vivo. Development 111: 131–143
128. Mintzer KA, Lee MA, Runke G, Trout J, Whitman M, Mullins MC. 2001 Lost-a-fin encodes a type I BMP receptor, Alk8, acting maternally and zygotically in dorsoventral pattern formation. Development 128: 859–869
129. Mitchell EJ, Lee K, O’Connor-McCourt MD. 1992 Characterization of transforming growth factor b (TGF-b) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-b binding glycoprotein. Mol Biol Cell 3: 1295–1307
130. Miyazono K, Hellman U, Wernstedt C, Heldin CH. 1988 Latent high molecular weight complex of transforming growth factor b1 Purification from human platelets and structural characterization. J Biol Chem 263: 6407–6415
131. Miyazono K, Olofsson A, Colosetti P, Heldin CH. 1991 A role of the latent TGF-b1-binding protein in the assembly and secretion of TGF-b1 EMBO J 10: 1091–1101
132. Miyazono K, Kusanagi K, Inoue H. 2001 Divergence and convergence of TGF-b/BMPsignaling. J Cell Physiol 187: 265–276
133. Miyazono K, Kamiya Y, Morikawa M. 2010 Bone morphogenetic protein receptors and signal transduction. J Biochem 147: 35–51
134. Moses HL, Proper JA, Volkenant ME, Wells DJ, Getz MJ. 1978 Mechanism of growth arrest of chemically transformed cells in culture. Cancer Res 38: 2807–2812
135. Moses HL, Wells DJ, Swartzendruber DE, Getz MJ. 1979 Comparison of RNA metabolism in G1-arrested and stimulated nontransformed and chemically transformed mouse embryo cells in culture. Cancer Res 39: 4516–4524
136. Moses HL, Branum EL, Proper JA, Robinson RA. 1981 Transforming growth factor production by chemically transformed cells. Cancer Res 41: 2842–2848
137. Moses HL, Tucker RF, Leof EB, Coffey RJ Jr., Halper J, Shipley GD. 1985 Type b transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells 3: 65–71
138. Moustakas A, Heldin CH. 2005.Non-Smad TGF-b signals. J Cell Sci 118: 3573–3584
139. Mucsi I, Skorecki KL, Goldberg HJ. 1996 Extracellular signal- regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor b1 on gene expression. J Biol Chem 271: 16567–16572
140. Mulder KM, Morris SL. 1992 Activation of p21ras by transforming growth factor b in epithelial cells. J Biol Chem 267: 5029–5031
141. Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H. 1986 Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. Cold Spring Harb Symp Quant Biol 51: 263–273
142. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al. 1997 Identification of Smad7, a TGF-b-inducible antagonist of TGF-b signalling. Nature 389: 631–635
143. Nieto MA. 2011 The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27: 347–376
144. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS. 1995 Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270: 22522–22526
145. O’Connor-McCourt MD, Wakefield LM. 1987 Latent transforming growth factor b in serum. A specific complex with a2-macroglobulin. J Biol Chem 262: 14090–14099
146. Overall CM, Wrana JL, Sodek J. 1989 Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor b. J Biol Chem 264: 1860–1869
147. Padgett RW, St Johnston RD, Gelbart WM. 1987 A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor b family. Nature 325: 81–84
148. Pelton RW, Nomura S, Moses HL, Hogan BL. 1989 Expression of transforming growth factor b2 RNA during murine embryogenesis. Development 106: 759–767
149. Pelton RW, Dickinson ME, Moses HL, Hogan BL. 1990a. In situ hybridization analysis of TGF-b3 RNA expression during mouse development: Comparative studies with TGF-b1 and b2 Development 110: 609–620
150. Pelton RW, Hogan BL, Miller DA, Moses HL. 1990b. Differential expression of genes encoding TGFs b1, b2, and b3 during murine palate formation. Dev Biol 141: 456–460
151. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. 1991 Immunohistochemical localization of TGF-b1, TGF-b2, and TGF-b3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115: 1091–1105
152. Pickup M, Novitskiy S, Moses HL. 2013 The roles of TGFb in the tumour microenvironment. Nat Rev Cancer 13: 788–799
153. Pierce DF Jr., Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL. 1993 Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-b1 Genes Dev 7: 2308–2317
154. PierceDF Jr., Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr., Moses HL. 1995 Mammary tumor suppression by transforming growth factor b1 transgene expression. Proc Natl Acad Sci 92: 4254–4258
155. Pircher R, Lawrence DA, Jullien P. 1984 Latent b transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res 44: 5538–5543
156. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. 1987 Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor b. J Exp Med 165: 251–256
157. Potts JD, Dagle JM, Walder JA, Weeks DL, Runyan RB. 1991 Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor b3 Proc Natl Acad Sci 88: 1516–1520
158. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T. 1995 Transforming growth factor b3 is required for secondary palate fusion. Nat Genet 11: 409–414
159. Proper JA, Bjornson CL, Moses HL. 1982 Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture. J Cell Physiol 110: 169–174
160. Raftery LA, Twombly V, Wharton K, Gelbart WM. 1995 Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 139: 241– 254
161. Roberts AB. 1995 Transforming growth factor b: Activity and efficacy in animal models of wound healing. Wound Repair Regen 3: 408–418
162. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ. 1980 Transforming growth factors: Isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci 77: 3494–3498
163. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. 1981 New class of transforming growth factors potentiated by epidermal growth factor: Isolation from nonneoplastic tissues. Proc Natl Acad Sci 78: 5339–5343
164. Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan YC, Stein S, Lehrman SR, Smith JM, Lamb LC, et al. 1983a. Purification and properties of a type b transforming growth factor from bovine kidney. Biochemistry 22: 5692–5698
165. Roberts AB, Frolik CA, Anzano MA, Sporn MB. 1983b. Transforming growth factors from neoplastic and nonneoplastic tissues. Fed Proc 42: 2621–2626
166. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. 1985 Type b transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci 82: 119–123
167. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al. 1986 Transforming growth factor type b: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 83: 4167–4171
168. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA. 1988 Transforming growth factor b stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 263: 4586–4592
169. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS. 1986 Effects of transforming growth factor b on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136: 3916–3920
170. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. 1995 Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci 92: 7632–7636
171. Ruberte E, Marty T, Nellen D, Affolter M, Basler K. 1995 An absolute requirement for both the type II and type I receptors, punt and thick veins, for dpp signaling in vivo. Cell 80: 889–897
172. Russell WE, Coffey RJ Jr., Ouellette AJ, Moses HL. 1988 Type b transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci 85: 5126–5130
173. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. 1997 TGF-b2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-b knockout phenotypes. Development 124: 2659–2670
174. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. 1990 Characterization of the activation of latent TGF-b by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J Cell Biol 111: 757–763
175. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, Padgett RW. 1996 Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor b pathway components. Proc Natl Acad Sci 93: 790–794
176. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. 1995 Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139: 1347–1358
177. Seyedin SM, Segarini PR, Rosen DM, Thompson AY, Bentz H, Graycar J. 1987 Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor b. J Biol Chem 262: 1946–1949
178. Sharples K, Plowman GD, Rose TM, Twardzik DR, Purchio AF. 1987 Cloning and sequence analysis of simian transforming growth factor b cDNA. DNA 6: 239–244
179. Shipley GD, Pittelkow MR, Wille JJ Jr., Scott RE, Moses HL. 1986 Reversible inhibition of normal human prokeratinocyte proliferation by type b transforming growth factor- growth inhibitor in serum-free medium. Cancer Res 46: 2068–2071
180. Shore EM, Kaplan FS. 2010 Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol 6: 518–527
181. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. 1992 Targeted disruption of the mouse transforming growth factor b1 gene results in multifocal inflammatory disease. Nature 359: 693–699
182. Silberstein GB, Daniel CW. 1987 Reversible inhibition of mammary gland growth by transforming growth factor b. Science 237: 291–293
183. Sporn MB, Todaro GJ. 1980 Autocrine secretion and malignant transformation of cells. N Engl J Med 303: 878–880
184. Sporn MB, Roberts AB, Shull JH, Smith JM, Ward JM, Sodek J. 1983 Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 219: 1329–1331
185. Stehelin D, Varmus HE, Bishop JM, Vogt PK. 1976 DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170–173
186. Swanstrom R, Parker RC, Varmus HE, Bishop JM. 1983 Transduction of a cellular oncogene: The genesis of Rous sarcoma virus. Proc Natl Acad Sci 80: 2519–2523.
187. ten Dijke P, Hill CS. 2004 New insights into TGF-b-Smad signalling. Trends Biochem Sci 29: 265–273.
188. ten Dijke P, Hansen P, Iwata KK, Pieler C, Foulkes JG. 1988 Identification of another member of the transforming growth factor type b gene family. Proc Natl Acad Sci 85: 4715–4719.
189. ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K. 1993 Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879–2887.
190. ten Dijke P, Miyazono K, Heldin CH. 2000 Signaling inputs converge on nuclear effectors in TGF-b signaling. Trends Biochem Sci 25: 64–70
191. Todaro GJ, Huebner RJ. 1972 N.A.S. symposium: New evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci 69: 1009–1015
192. Todaro GJ, De Larco JE, Cohen S. 1976 Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature 264: 26–31
193. Todaro GJ, De Larco JE, Marquardt H, Bryant ML, Sherwin SA, Sliski AH. 1979 Polypeptide growth factors produced by tumor cells and virus-transformed cells: A possible growth advantage for the producer cells. In Hormones and cell culture. Cell proliferation conference, Vol. 6, pp. 113–127 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
194. Tsuji T, Okada F, Yamaguchi K, Nakamura T. 1990 Molecular cloning of the large subunit of transforming growth factor type b masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci 87: 8835–8839
195. Tsuneizumi K, Nakayama T, Kamoshida Y, Kornberg TB, Christian JL, Tabata T. 1997 Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 389: 627–631
196. Tuan TL, Cheung DT, Wu LT, Yee A, Gabriel S, Han B, Morton L, Nimni ME, Hall FL. 1996 Engineering, expression and renaturation of targeted TGF-b fusion proteins. Connect Tissue Res 34: 1–9
197. Tucker RF, Branum EL, Shipley GD, Ryan RJ, Moses HL. 1984a. Specific binding to cultured cells of 125I-labeled type b transforming growth factor from human platelets. Proc Natl Acad Sci 81: 6757–6761
198. Tucker RF, Shipley GD, Moses HL, Holley RW. 1984b. Growth inhibitor from BSC-1 cells closely related to platelet type b transforming growth factor. Science 226: 705–707
199. Ventura F, Liu F, Doody J, Massagué J. 1996 Interaction of transforming growth factor-b receptor I with farnesylprotein transferase-a in yeast and mammalian cells. J Biol Chem 271: 13931–13934
200. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. 1987 Transforming growth factor type b induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci 84: 5788–5792
201. Wakefield LM, Smith DM, Flanders KC, Sporn MB. 1988 Latent transforming growth factor b from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem 263: 7646–7654
202. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. 1991 Expression cloning and characterization of the TGF-b type III receptor. Cell 67: 797–805
203. Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK. 1996a The immunophilin FKBP12 functions as a common inhibitor of the TGF-b family type I receptors. Cell 86: 435–444
204. Wang T, Danielson PD, Li BY, Shah PC, Kim SD, Donahoe PK. 1996b. The p21RAS farnesyltransferase a subunit in TGF-b and activin signaling. Science 271: 1120–1122
205. Webb NR, Madisen L, Rose TM, Purchio AF. 1988 Structural and sequence analysis of TGF-b2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing. DNA 7: 493–497
206. Weeks DL,MeltonDA. 1987 A maternalmRNA localized to the vegetal hemisphere in Xenopus eggs codes for a growth factor related to TGF-b. Cell 51: 861–867
207. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988 Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528–1534
208. Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J. 1992 TGF-b signals through a heteromeric protein kinase receptor complex. Cell 71: 1003–1014
209. Wrana JL, Tran H, Attisano L, Arora K, Childs SR, Massagué J, O’Connor MB. 1994a. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol Cell Biol 14: 944–950
210. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. 1994b. Mechanism of activation of the TGF-b receptor. Nature 370: 341–347
211. Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer E, Fontana A. 1987 T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor b. EMBO J 6: 1633–1636
212. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-b signal transduction. Science 270: 2008–2011
213. Yan Z, Winawer S, Friedman E. 1994 Two different signal transduction pathways can be activated by transforming growth factor b1 in epithelial cells. J Biol Chem 269: 13231–13237
214. Ying SY, Becker A, Ling N, Ueno N, Guillemin R. 198 Inhibin and b type transforming growth factor (TGFb) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochem Biophys Res Commun 136: 969–975
215. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE. 1998 Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611–617
216. Zhang YE. 2009 Non-Smad pathways in TGF-b signaling. Cell Res 19: 128–139
217. Zhang Y, Feng XH, Wu R, Derynck R. 1996 Receptor-associated Mad homologues synergize as effectors of the TGF-b response. Nature 383: 168–172
218. Zhang Y, Musci T, Derynck R. 1997 The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol 7: 270–276
219. Zhang Y, Feng XH, Derynck R. 1998 Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-b-induced transcription. Nature 394: 909–913 (Erratum in Nature 396: 491).